Sonia Savur

Sonia Savur

Auto-generated profile, based on publicly available information

Sonia Savur

University of California, San Francisco

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 June 2026 in medRxiv
Verified
Preprint
Open access
PDF file
RCRyan Chung
Ryan Chung
NCNamratha Shivani Chalasani
Namratha Shivani Chalasani
ABAlton S. Barbehenn
Alton S. Barbehenn
ELErik Lundgren
Erik Lundgren
SSSonia Savur
Sonia Savur
SLSulggi Lee
Sulggi Lee
People with HIV exhibit elevated inflammation and cardiovascular risk despite antiretroviral therapy. To define the genetic architecture of inflammasome-associated inflammation, we performed whole-genome sequencing and quantified plasma IL-6, IL-1β, and IL-18 in 1,000 ART-suppressed PWH from the U.S. Military HIV Natural History Study. Genome-wide analyses identified 14 loci implicating antiviral defense (DDX17, DDX41, EEA1, BCL11A), lipid metabolism (ABCA1, ABCA12, ABCC1, AGMO), and vascular remodeling (KLHL29, RNF213, ETV1). Transcriptome-wide analyses across cardiovascular and immune tissues identified regulatory programs linking interferon signaling, immune activation, and vascular biology to circulating cytokine levels. Mendelian randomization analyses supported causal relationships between inflammasome-associated cytokines and vascular events. Functional integration with genome-wide CRISPR perturbation datasets in primary CD4⁺ T cells linked cytokine-associated loci to HIV antiviral pathways and cytokine regulatory networks. External validation in cohorts without HIV demonstrated pathway-level convergence despite limited variant-level overlap. These findings define genetic mechanisms linking inflammasome signaling, antiviral defense, and cardiovascular risk.

10 August 2026 in medRxiv
Verified
Preprint
Open access
PDF file
ABAlton S. Barbehenn
Alton S. Barbehenn
CSCaroline H. Sheikhzadeh
Caroline H. Sheikhzadeh
SSSonia Savur
Sonia Savur
ELErik Lundgren
Erik Lundgren
SSSannidhi Sarvadhavabhatla
Sannidhi Sarvadhavabhatla
SLSulggi Lee
Sulggi Lee
Importance: The immune mechanisms driving vascular disease remain incompletely understood. People with HIV (PWH), even during effective antiretroviral therapy (ART), exhibit persistent immune activation and inflammation, which may contribute to higher rates of vascular disease and mortality compared with people without HIV (PWoH). Leveraging a cohort of U.S. military personnel followed from HIV diagnosis through long-term ART suppression, we sought to identify immunologic pathways underlying increased vascular risk. Objective: To identify plasma biomarkers reflecting distinct immune mechanisms that predict incident vascular outcomes in ART-suppressed PWH. Design: Case-cohort study within the U.S. Military HIV Natural History Study. Setting: Longitudinal, multicenter observational cohort. Participants: A total of 1,002 ART-suppressed PWH (HIV RNA <50 copies/mL) were included, with N=135 vascular event (VE) cases and N=702 controls. Cases encompassed atherosclerotic cardiovascular disease (ASCVD) – coronary artery disease (CAD), myocardial infarction (MI), stroke (CVA), peripheral artery disease (PAD) – and venous thrombotic events (VTE) – deep vein thrombosis (DVT) and pulmonary embolism (PE). Exposures: Thirty-three soluble plasma analytes quantified using a high-sensitivity multiplex assay from samples collected ≥1 year after ART suppression. Main Outcomes and Measures: The primary outcome was incident ASCVD. Associations between cytokine concentrations (individual and clustered) and vascular risk were evaluated using unsupervised clustering, Cox proportional hazards models, and causal inference (to estimate 5-year ASCVD risk under hypothetical cytokine alterations). Mediation analyses assessed direct and indirect effects of key inter-related cytokines. Secondary outcome included any VE (ASCVD plus VTE). Covariates included traditional cardiovascular risk factors, HIV clinical variables, and demographics. False discovery rate (FDR) adjustment was applied using the Benjamini-Hochberg method. Results: Cytokine clusters reflecting NLRP3 inflammasome activation and persistent inflammation (IL-18, IL-6) and individual markers (IL-18: HR=1.89, q=0.007; TGF-β2: HR=0.74, q=0.026) were associated with increased ASCVD risk. IL-18 remained nominally significant after adjusting for traditional risk factors (p<0.05) but did not meet FDR significance (q<0.05). Conclusions and Relevance: NLRP3 inflammasome activation and reduced TGF-β2, indicating loss of anti-inflammatory and repair mechanisms, may contribute to atherogenesis in ART-suppressed PWH. These findings highlight potential interventional targets for mitigating inflammation-driven vascular risk and warrant validation in larger cohorts to inform novel therapeutic strategies. Key Points: Question: Which inflammatory immune pathways are associated with incident atherosclerotic cardiovascular disease in ART-suppressed people with HIV? Findings: In this longitudinal case-cohort study of 1,002 ART-suppressed people with HIV, elevated IL-18 and reduced TGF-β2 were associated with incident ASCVD. Associations were specific to arterial rather than venous events, and IL-18-related risk was partly mediated through IL-6. Meaning: These findings suggest that imbalance between inflammasome-driven inflammation and impaired immune regulation contributes to residual cardiovascular risk in treated HIV.

21 August 2026 in medRxiv
Verified
Preprint
Open access
PDF file
ABAlton Barbehenn
Alton Barbehenn
ELErik Lundgren
Erik Lundgren
SSSonia Savur
Sonia Savur
LSLei Shi
Lei Shi
JSJunzhe Shao
Junzhe Shao
SLSulggi Lee
Sulggi Lee
Background: The HIV reservoir is established within days of infection and persists despite antiretroviral therapy (ART). Host immune responses associated with early reservoir decay remain poorly defined. Methods: We analyzed > 500 longitudinal blood samples from 67 individuals treated during acute HIV infection. Plasma cytokines and HIV reservoir size (intact and defective DNA) were quantified longitudinally. Cytokine–reservoir relationships were assessed using unsupervised clustering and complementary mixed-effects nonlinear and linear spline models; counterfactual modeling examined how cytokine concentrations at defined timepoints related to subsequent reservoir trajectories. Results: TNF-α, IL-17A, and IL-10 were significantly associated with intact HIV DNA during the first 24 weeks of ART after false-discovery-rate correction. TNF-α showed one of the strongest associations with intact reservoir decay, whereas IL-10 showed the most consistent association across intact and defective HIV DNA. A coordinated cytokine cluster comprising IFN-γ, IL-10, IL-18, and TNF-α was associated with both reservoir measures. Phase-specific and counterfactual analyses further suggested that associations between several cytokines and reservoir dynamics varied with timing during early ART. These relationships persisted after adjustment for ART initiation timing, baseline viremia, initial CD4+ T-cell count, and longitudinal CD4:CD8 ratio. Discussion: Coordinated inflammatory, antiviral, and immunoregulatory cytokine responses are associated with HIV reservoir decay following ART initiation during acute infection, with some relationships varying over time. These findings may inform future stage-specific HIV cure strategies that leverage the timing and balance of antiviral, inflammatory, and immunoregulatory pathways to limit reservoir persistence. Main Summary: In people initiating ART during acute HIV infection, coordinated inflammatory, antiviral, and immunoregulatory cytokine responses were associated with faster HIV reservoir decay, with TNF-α and IL-10 showing particularly strong and consistent associations.